235 related articles for article (PubMed ID: 16757911)
21. Is nuchal translucency a useful aneuploidy marker in fetuses with crown-rump length of 28-44 mm?
Grande M; Solernou R; Ferrer L; Borobio V; Jimenez JM; Bennasar M; Soler A; Borrell A
Ultrasound Obstet Gynecol; 2014 May; 43(5):520-4. PubMed ID: 24006271
[TBL] [Abstract][Full Text] [Related]
22. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
[TBL] [Abstract][Full Text] [Related]
23. Predictive value of increased nuchal translucency as a screening test for the detection of fetal chromosomal abnormalities.
Alexioy E; Alexioy E; Trakakis E; Kassanos D; Farmakidis G; Kondylios A; Laggas D; Salamalekis E; Florentin L; Kanavakis E; Basios G; Trompoukis P; Georgiadoy L; Panagiotopoulos T
J Matern Fetal Neonatal Med; 2009 Oct; 22(10):857-62. PubMed ID: 19521928
[TBL] [Abstract][Full Text] [Related]
24. First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population.
Chasen ST; Sharma G; Kalish RB; Chervenak FA
Ultrasound Obstet Gynecol; 2003 Aug; 22(2):149-51. PubMed ID: 12905508
[TBL] [Abstract][Full Text] [Related]
25. Interest of foetal nasal bone measurement at first trimester trisomy 21 screening.
Weingertner AS; Kohler M; Firtion C; Vayssière C; Favre R
Fetal Diagn Ther; 2006; 21(5):433-8. PubMed ID: 16912493
[TBL] [Abstract][Full Text] [Related]
26. Screening for trisomy 21 in monochorionic twins by measurement of fetal nuchal translucency thickness.
Vandecruys H; Faiola S; Auer M; Sebire N; Nicolaides KH
Ultrasound Obstet Gynecol; 2005 Jun; 25(6):551-3. PubMed ID: 15880648
[TBL] [Abstract][Full Text] [Related]
27. First-trimester screening for chromosomal abnormalities by fetal nuchal translucency in a Brazilian population.
Brizot ML; Carvalho MH; Liao AW; Reis NS; Armbruster-Moraes E; Zugaib M
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):652-5. PubMed ID: 11844209
[TBL] [Abstract][Full Text] [Related]
28. Screening for Down syndrome based on maternal age or fetal nuchal translucency: a randomized controlled trial in 39,572 pregnancies.
Saltvedt S; Almström H; Kublickas M; Valentin L; Bottinga R; Bui TH; Cederholm M; Conner P; Dannberg B; Malcus P; Marsk A; Grunewald C
Ultrasound Obstet Gynecol; 2005 Jun; 25(6):537-45. PubMed ID: 15912479
[TBL] [Abstract][Full Text] [Related]
29. A mixture model of nuchal translucency thickness in screening for chromosomal defects.
Wright D; Kagan KO; Molina FS; Gazzoni A; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Apr; 31(4):376-83. PubMed ID: 18383462
[TBL] [Abstract][Full Text] [Related]
30. Nuchal translucency measurement at different crown-rump lengths along the 10- to 14-week period for Down syndrome screening.
Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C; Monni G
Prenat Diagn; 2005 May; 25(5):411-6. PubMed ID: 15906410
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of first-trimester screening by fetal nuchal translucency and maternal age.
Theodoropoulos P; Lolis D; Papageorgiou C; Papaioannou S; Plachouras N; Makrydimas G
Prenat Diagn; 1998 Feb; 18(2):133-7. PubMed ID: 9516014
[TBL] [Abstract][Full Text] [Related]
32. Fetal nuchal translucency scan and early prenatal diagnosis of chromosomal abnormalities by rapid aneuploidy screening: observational study.
Chitty LS; Kagan KO; Molina FS; Waters JJ; Nicolaides KH
BMJ; 2006 Feb; 332(7539):452-5. PubMed ID: 16476673
[TBL] [Abstract][Full Text] [Related]
33. Comparison between two methods of standardization for gestational age differences in fetal nuchal translucency measurement in first-trimester screening for trisomy 21.
Biagiotti R; Periti E; Brizzi L; Vanzi E; Cariati E
Ultrasound Obstet Gynecol; 1997 Apr; 9(4):248-52. PubMed ID: 9168573
[TBL] [Abstract][Full Text] [Related]
34. Pregnancy outcomes with increased nuchal translucency after routine Down syndrome screening.
Cheng CC; Bahado-Singh RO; Chen SC; Tsai MS
Int J Gynaecol Obstet; 2004 Jan; 84(1):5-9. PubMed ID: 14698823
[TBL] [Abstract][Full Text] [Related]
35. Establishment and application of a normal range for nuchal translucency across the first trimester.
Scott F; Boogert A; Sinosich M; Anderson J
Prenat Diagn; 1996 Jul; 16(7):629-34. PubMed ID: 8843472
[TBL] [Abstract][Full Text] [Related]
36. Distribution of nuchal translucency thickness in Japanese fetuses.
Hasegawa J; Nakamura M; Hamada S; Matsuoka R; Ichizuka K; Sekizawa A; Okai T
J Obstet Gynaecol Res; 2013 Apr; 39(4):766-9. PubMed ID: 23107008
[TBL] [Abstract][Full Text] [Related]
37. First-trimester Down's syndrome screening by fetal nuchal translucency measurement in Taiwan.
Jou HJ; Shih JC; Wu SC; Li TC; Tzeng CY; Hsieh FJ
J Formos Med Assoc; 2001 Apr; 100(4):257-61. PubMed ID: 11393125
[TBL] [Abstract][Full Text] [Related]
38. Fetal nuchal translucency scan in Nigeria.
Oloyede OA; Abbey M; Oloyede AA; Nwachukwu O
Pan Afr Med J; 2014; 18():62. PubMed ID: 26113896
[TBL] [Abstract][Full Text] [Related]
39. Outcome of fetal exomphalos diagnosed at 11-14 weeks of gestation.
Khalil A; Arnaoutoglou C; Pacilli M; Szabo A; David AL; Pandya P
Ultrasound Obstet Gynecol; 2012 Apr; 39(4):401-6. PubMed ID: 21793081
[TBL] [Abstract][Full Text] [Related]
40. [Ultrasound soft markers and fetal cardiac structural assessment at 11-14 weeks].
Yang Y; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2014 Mar; 49(3):188-92. PubMed ID: 24820303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
